로딩 중…
지수 로딩 중…
Scribe Therapeutics Inc. Common Stock
SCTX· NASDAQ· Health Care
$17.44-0.57%
2026-10-29
Valuation Metrics
Scribe Therapeutics Inc. Common Stock's Market Cap is $282M. Ranked #2915 of 3,115 in US market (top 94%), #1318 of 1,472 on NASDAQ (top 90%) by Market Cap.
Investment Metrics(as of 2026-10-29)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $282M | US#2,915/3,115 |
| Employees | 89 | US#2,639/3,115 |
| Performance | ||
| 1M Return | -24.27% | US#2,889/3,115 |
| From 52W High | -55.96% | US#2,791/3,115 |
| 1Y MDD | -58.63% | US#2,698/3,115 |
| Trading | ||
| Volume | 237,918 shares | US#2,389/3,115 |
| Trading Value | $4M | US#2,595/3,115 |
Company Info
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.